Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.

When CVS Health (CVS) jumped, trading above $60, the rally did not last. Markets initially responded well to CVS’s Q3 results ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective ...

Tenthoff covers the Healthcare sector, focusing on stocks such as Sutro Biopharma, Moderna, and Arrowhead Pharmaceuticals ... Philippe Lamarre in 2005 and is headquartered in Montreal, Canada. Read ...

This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Conference Call and Webcast Extendicare will hold a conference call to discuss its 2024 third ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

The health sector faces diverse challenges, from Italy's Recordati dismissing concerns about potential U.S. tariffs on ...

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective dropped by research analysts at Barclays from $125.00 to $111 ...

Italy's Recordati expects minimal impact from proposed U.S. pharma tariffs. Canada's Health Canada approves Moderna's RSV ...